Cargando…

Effect of vortioxetine on proinflammatory cytokine levels in patients with heart failure and comorbid depression

INTRODUCTION: Several studies have shown impaired cytokine status in both patients with depression and chronic heart failure (HF). OBJECTIVES: to study the effect of vortioxetine on the level of pro-inflammatory cytokines: interleukin -1β (IL-1β) and interleukin - 6 (IL-6). METHODS: there were exami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sikora, A., Fedorov, S., Pityk, O., Vynnyk, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471139/ http://dx.doi.org/10.1192/j.eurpsy.2021.269

Ejemplares similares

The soluble ST2 levels in patients with depression and comorbid heart failure
por: Sikora, A., et al.
Publicado: (2022)

The power of multimodal antidepressants: decrease of soluble ST2 blood level in patients with depression and comorbid heart failure
por: Sikora, A. K., et al.
Publicado: (2023)

Optimizing the Correction of Depressive Disorders in Patients with Primary Hypothyroidism
por: Pityk, O. M.
Publicado: (2023)

Emotional blunting and cognitive profile in elderly depressed patients in treatment with vortioxetine
por: Franza, F., et al.
Publicado: (2021)

Spice related catatonia and its treatment: The case study
por: Pityk, O., et al.
Publicado: (2021)

A Case of Severe Somatized Depression in a Young Adult: Diagnostic Challenges
por: Pityk, O. M., et al.
Publicado: (2023)

Assessment of quality of life in patients with primary hypothyroidism - the main criterion of treatment effectiveness
por: Pityk, O.
Publicado: (2021)

Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study
por: Christensen, Michael Cronquist, et al.
Publicado: (2022)

Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression
por: Segura-Garcia, Cristina, et al.
Publicado: (2021)

Paternal postpartum depression in an obsessive personality following the COVID-19 lockdown successfully treated with Vortioxetine
por: Orsolini, L., et al.
Publicado: (2022)

ET-11 ANALYSIS OF ANTI-GLIOMA EFFECT BY PROINFLAMMATORY CYTOKINES
por: Adachi, Koji, et al.
Publicado: (2019)

Cytokines status in multiple sclerosis patients with comorbid recurrent depressive disorder
por: Markova, E., et al.
Publicado: (2021)

The impact of dose on the real-world effectiveness of vortioxetine in outpatients with mdd in greece
por: Papalexi, E., et al.
Publicado: (2021)

PS110. Reversal of stress-induced anhedonia by the multimodel antidepressant, vortioxetine
por: Christensen, AK, et al.
Publicado: (2016)

P03-004 - Production of proinflammatory cytokines in PFAPA
por: Kozlova, A, et al.
Publicado: (2013)

Assessment of psychopathological symptoms in patients with primary hypothyroidism
por: Pityk, O., et al.
Publicado: (2022)

Effectiveness of vortioxetine in real-world clinical practice: Interim results from the relieve study
por: Mattingly, G., et al.
Publicado: (2021)

Vortioxetine Improved Depressive State In Parkinson’s Disease
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression
por: Shao, Shichuan, et al.
Publicado: (2022)

Social-Stress Disorder and Post-Traumatic Stress Disorder in Ukrainian Population.
por: Pityk, O. M.
Publicado: (2023)

Comorbidities and Consequences in Hospitalized Heart Failure Patients with Depression
por: Patel, Rikinkumar S, et al.
Publicado: (2018)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019)

The effect of vortioxetine on overall patient functioning in patients with major depressive disorder
por: Florea, Ioana, et al.
Publicado: (2017)

Effects of Vortioxetine on Sleep Architecture of Adolescents with Major Depressive Disorder
por: Mlyncekova, Zuzana, et al.
Publicado: (2023)

Antidepressant Effects on Insulin Sensitivity and Proinflammatory Cytokines in the Depressed Males
por: Chen, Yi-Chyan, et al.
Publicado: (2010)

The relationship between the plasma proinflammatory cytokine levels of depressed/anxious children and their parents
por: Mevorach, Tomer, et al.
Publicado: (2021)

Healthcare Disparity and Comorbidity Burden in Heart Failure Patients Over the Age of 80
por: Blach, Anna, et al.
Publicado: (2021)

Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
por: Tarakçioğlu, Mehmet, et al.
Publicado: (2003)

Efficacy of vortioxetine on the physical symptoms of major depressive disorder
por: Christensen, Michael Cronquist, et al.
Publicado: (2018)

Effectiveness of vortioxetine in real-world clinical practice: Italian cohort results from the global RELIEVE study
por: De Filippis, S., et al.
Publicado: (2022)

Effectiveness of vortioxetine in real-world clinical practice: French cohort results from the global RELIEVE study
por: Polosan, M., et al.
Publicado: (2022)

Comparative efficacy and safety of escitalopram, desvenlafaxine, and vortioxetine in the acute treatment of anxious depression: A randomized rater-blinded, 6-week clinical trial
por: Oh, K.-S., et al.
Publicado: (2022)

Proinflammatory Cytokines Correlate with Depression and Anxiety in Colorectal Cancer Patients
por: Oliveira Miranda, Diego, et al.
Publicado: (2014)

Human vascular endothelial cells produce TNF-α after stimulation with proinflammatory cytokines
por: Ranta, V, et al.
Publicado: (1999)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez, Enric, et al.
Publicado: (2014)

Gut Microbiota Changes in Patients With Major Depressive Disorder Treated With Vortioxetine
por: Ye, Xiaolin, et al.
Publicado: (2021)

Clinical effectiveness of vortioxetine in postcovid syndrome
por: Vikarenko, M., et al.
Publicado: (2022)

Proinflammatory activation profile in circulating monocytes in patients with a major depressive episode
por: Grendas, L., et al.
Publicado: (2023)

Alprazolam addiction: The case study
por: Pityk, O., et al.
Publicado: (2021)

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects
por: Papalexi, Eugenia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pc26unlh1jn9o19tedj07t9d70